The Role of EGFR/PI3K/Akt/cyclinD1 Signaling Pathway in Acquired Middle Ear Cholesteatoma
Cholesteatoma is a benign keratinizing and hyper proliferative squamous epithelial lesion of the temporal bone. Epidermal growth factor (EGF) is one of the most important cytokines which has been shown to play a critical role in cholesteatoma. In this investigation, we studied the effects of EGF on...
Saved in:
Main Authors: | Wei Liu, Hongmiao Ren, Jihao Ren, Tuanfang Yin, Bing Hu, Shumin Xie, Yinghuan Dai, Weijing Wu, Zian Xiao, Xinming Yang, Dinghua Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/651207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIAGNOSIS AND THERAPEUTIC MANAGEMENT OF COMPLICATED MIDDLE EAR CHOLESTEATOMA. A NARRATIVE REVIEW
by: Marius Cristian Mârțu, et al.
Published: (2024-12-01) -
Transcanal Endoscopic Ear Surgery for Pediatric Bilateral Congenital Cholesteatoma: A Report of Two Cases
by: Takashi Ueda, et al.
Published: (2025-11-01) -
Letter to the Editor Regarding “Esterified Hyaluronic Acid Placed in the Middle Ear Does Not Improve Outcomes in Cholesteatoma Surgery”
by: Mohammad Faramarzi, et al.
Published: (2023-03-01) -
Congenital Intralabyrinthine Cholesteatoma
by: Sanjay Prasad, et al.
Published: (2014-01-01) -
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors
by: Nathaniel J. Myall, MD, et al.
Published: (2025-02-01)